| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |